US2005287633A1PendingUtilityA1
Vanilloid receptor
Est. expiryMar 26, 2019(expired)· nominal 20-yr term from priority
C07K 14/705
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The isolated nucleic acid encoding human vanilloid receptor, said receptor, its preparation, cells expressing said receptor and an assay for testing compounds for their potential to decrease pain in humans. The receptor is involved in detection of noxious stimuli in mammalian organisms.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . (canceled)
3 . (canceled)
4 . (canceled)
5 . (canceled)
6 . (canceled)
7 . A recombinant human vanilloid receptor.
8 . The receptor of claim 7 encoded by a nucleic acid wherein the nucleic acid has sequence identity of from more than 85.5% to 100% over the open reading frame of SEQ ID NO:1.
9 . (canceled)
10 . The receptor of claim 7 wherein when the receptor is expressed in mammalian cells, the receptor can be activated by capsaicin, in the presence of temperatures greater than 42° C. and by pH less than 5.5.
11 . The receptor of claim 7 wherein activation by capsaicin, temperatures greater than 42° C. or by pH less than 5.5 is inhibited by the action of the capsaicin antagonist capsazepine.
12 . (canceled)
13 . (canceled)
14 . (canceled)
15 . (canceled)
16 . (canceled)
17 . (canceled)
18 . (canceled)
19 . An isolated human vanilloid receptorJoin the waitlist — get patent alerts
Track US2005287633A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.